Emily Cridland is a partner in the London office of Latham & Watkins and is a member of the firm’s Corporate Department.

Ms. Cridland trained in Latham's London and Singapore offices and spent time as an associate working in-house on secondment to Markit Group Limited (now part of S&P). Her practice focuses on cross-border mergers and acquisitions, joint ventures, venture capital, reorganisations, and general corporate matters for clients across a variety of industries.

In addition to her legal practice, Ms. Cridland is currently a Vice Chair of the firm’s Recruiting Committee, and has previously served on the firm’s Associates Committee.

Ms. Cridland’s representative transactions include advising:

  • atai Life Sciences on its investment into Beckley Psytech Limited, a clinical-stage biotechnology company focused on developing novel psychedelic therapies
  • System1, Inc. on the sale of Total Security Limited, a cybersecurity company, to a group led by Just Develop It Limited
  • Ericsson / Cradlepoint on its acquisition of cloud-based security specialist Ericom
  • IHS Markit on its joint venture with PIMCO, Man Property Holdings, State Street, and Microsoft to set up a new technology-led company, HUB, to build a cloud-based operating platform aimed at transforming asset managers’ operations technology
  • Novo Holdings A/S on its acquisition of BBI Group, a leading supplier of products and services to the global diagnostics and life sciences industries
  • Nordic Capital on its acquisition of ADVANZ PHARMA, a London-based pharmaceutical company
  • Ligand Pharmaceuticals on its sale of Vernalis (R&D) Limited, a UK-based fragment and structure-based drug discovery research company, to HitGen
  • Eleusis Holdings on its acquisition of Kalypso Treatment Centers, a leading provider of ketamine infusion therapies in the United States
  • Nestlé Health Science on its acquisition of Vital Proteins
  • Atnahs Pharma on its acquisition of assets related to five hypertension medicine brands from AstraZeneca
  • Thomas Cook Group in connection with its strategic review, re-financing and the proposed sale of its airline and ultimately its attempted recapitalization
  • Sony Pictures Entertainment and its subsidiary, Columbia Pictures Corporation, on the acquisition of Silvergate Media, a developer of children’s brands for broadcasters, streaming platforms, and retail partners (including the Octonauts, Peter Rabbit, and Hilda animated series)
  • GlaxoSmithKline on its:
    • Divestment of its Prevacid®24HR business to Perrigo Company
    • Divestment of assets relating to the Bialcol and Cibalgina brands in Italy to Vemedia
    • Divestment of certain North American consumer health assets to Crown Laboratories
    • Divestment of five over-the-counter dermatology brands and one pediatric cough remedy brand to the STADA Group
  • Peloton Advantage, a portfolio company of Amulet Capital Partners, on the acquisition of Open Health Communications, a UK-based provider of healthcare communications and market access services
  • Netflix on the acquisition of Millarworld, the comic book company founded by Mark Millar, creator of a number of iconic characters and stories, including Kick-Ass, Kingsman, and Old Man Logan, the first ever acquisition by Netflix
  • ACCO Brands Corporation in connection with its €296.9 million acquisition of Esselte Group, a leading European office products company, from private equity firm J.W. Childs
  • Astorg Partners on its acquisition of Audiotonix, a global producer of audio mixing consoles

Bar Qualification

  • England and Wales (Solicitor)


  • Postgraduate Diploma in Legal Practice, Nottingham Law School, 2010
  • Bachelor of Law (Hons), University of Sussex, 2008